Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted Debt Ratio of 0.07 for Q2 2024, down 30.89% on a QoQ basis from 0.1 in Q1 2024, and down 83.07% year-over-year from 0.42 in Q3 2023.
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings has reported Debt Ratio for 12 years, with the latest figure at 0.07 in Q2 2024.
- On a quarterly basis, Debt Ratio fell 83.07% year-over-year to 0.07 in Q2 2024; TTM through Jun 2024 was 0.07, a 83.07% decrease from a year earlier, with the FY2023 full-year figure at 1.14, up 293.71% from the prior year.
- Debt Ratio was 0.07 for Q2 2024 at Corbus Pharmaceuticals Holdings, down from 0.1 in the prior quarter.
- The five-year high for Debt Ratio was 1.14 in Q4 2023, with the low at 0.0 in Q2 2020.
- Average Debt Ratio over 5 years is 0.26, with a median of 0.19 recorded in 2020.
- The sharpest annual moves came in 2021 and 2024: Debt Ratio soared 14068.14% in 2021, then slumped 83.07% in 2024.
- Over 5 years, Debt Ratio stood at 0.18 in 2020, then declined by 1.66% to 0.18 in 2021, then surged by 59.43% to 0.29 in 2022, then surged by 293.71% to 1.14 in 2023, then tumbled by 93.73% to 0.07 in 2024.
- The last three Debt Ratio figures came in at 0.07 (Q2 2024), 0.1 (Q1 2024), and 1.14 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 1.14 |
| Sep 30, 2023 | 0.49 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.23 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.16 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.18 |
| Sep 30, 2020 | 0.19 |
| Jun 30, 2020 | 0.00 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.02 |
| Jun 30, 2019 | 0.00 |